Suitability for Consumption of Chyawanprakash-A Herbal Formulation in Controlled Type II Diabetics-A Open Label Clinical Study

Satyendra Kumar, Arun Gupta, Raman Ghungralekar, V. Deshpande
{"title":"Suitability for Consumption of Chyawanprakash-A Herbal Formulation in Controlled Type II Diabetics-A Open Label Clinical Study","authors":"Satyendra Kumar, Arun Gupta, Raman Ghungralekar, V. Deshpande","doi":"10.4172/2327-5162.1000230","DOIUrl":null,"url":null,"abstract":"Objective: Chyawanprakash, a Chyawanprash based proprietary Ayurvedic formulation in which conventional \n sugar and honey are replaced by permitted alternate sweeteners in diabetic population. \nDesign: This was a randomized open label clinical study conducted across two study sites in Maharashtra \n (India). 121 male and female subjects in the age range of 18-70 years who were suffering from Type II Diabetes \n mellitus for more than one year and were stabilized on either exercise/diet regimen or oral hypoglycemic agents \n were recruited in the study and advised 1 teaspoonful of Chyawanprakash twice daily orally after meals for 90 days. \n They were advised to continue their anti-diabetic medicines under the supervision of the Investigator. Results were \n assessed basis pre and post treatment changes in glycosyated hemoglobin (HbA1c) and the Physician global \n assessment of overall safety. Clinical symptoms, laboratory parameters like blood sugar and insulin levels, \n microalbuminuria, liver and renal function tests, lipid profiles etc and changes in dose of oral hypoglycemic agents \n were also assessed. \nResults: Oral administration of Chyawanprakash in recommended dosage in controlled Type II diabetics did not \n show any safety concern which was evident by no statistically significant change in HbA1c levels and the clinical as \n well as laboratory parameters (blood sugar, microalbuminuria, liver and renal function tests, lipid profiles etc). 97% \n excellent safety was reported on the Physician’s global assessment of overall safety. Moreover, a statistically \n significant improvement was also observed in energy levels of subjects. \nConclusion: Results concluded the suitability of Chyawanprakash in controlled Type II diabetics.","PeriodicalId":90094,"journal":{"name":"Alternative & integrative medicine","volume":"6 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative & integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2327-5162.1000230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Objective: Chyawanprakash, a Chyawanprash based proprietary Ayurvedic formulation in which conventional sugar and honey are replaced by permitted alternate sweeteners in diabetic population. Design: This was a randomized open label clinical study conducted across two study sites in Maharashtra (India). 121 male and female subjects in the age range of 18-70 years who were suffering from Type II Diabetes mellitus for more than one year and were stabilized on either exercise/diet regimen or oral hypoglycemic agents were recruited in the study and advised 1 teaspoonful of Chyawanprakash twice daily orally after meals for 90 days. They were advised to continue their anti-diabetic medicines under the supervision of the Investigator. Results were assessed basis pre and post treatment changes in glycosyated hemoglobin (HbA1c) and the Physician global assessment of overall safety. Clinical symptoms, laboratory parameters like blood sugar and insulin levels, microalbuminuria, liver and renal function tests, lipid profiles etc and changes in dose of oral hypoglycemic agents were also assessed. Results: Oral administration of Chyawanprakash in recommended dosage in controlled Type II diabetics did not show any safety concern which was evident by no statistically significant change in HbA1c levels and the clinical as well as laboratory parameters (blood sugar, microalbuminuria, liver and renal function tests, lipid profiles etc). 97% excellent safety was reported on the Physician’s global assessment of overall safety. Moreover, a statistically significant improvement was also observed in energy levels of subjects. Conclusion: Results concluded the suitability of Chyawanprakash in controlled Type II diabetics.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
chyawanprakash -一种草药制剂在控制型糖尿病患者中的适宜性——一项开放标签临床研究
目的:Chyawanprakash,一种基于Chyawanprash的专有阿育吠陀配方,在糖尿病人群中,传统的糖和蜂蜜被允许的替代甜味剂取代。设计:这是一项随机开放标签临床研究,在马哈拉施特拉邦(印度)的两个研究地点进行。本研究招募了121名年龄在18-70岁之间的男性和女性受试者,他们患有II型糖尿病超过一年,并且在运动/饮食方案或口服降糖药方面病情稳定,并建议他们在90天内每天两次口服1茶匙恰万普拉卡。建议他们在研究者的监督下继续服用抗糖尿病药物。根据治疗前和治疗后糖化血红蛋白(HbA1c)的变化以及医师对总体安全性的全球评估来评估结果。还评估了临床症状、实验室参数,如血糖和胰岛素水平、微量白蛋白尿、肝肾功能测试、脂质状况等,以及口服降糖药剂量的变化。结果:对照II型糖尿病患者按推荐剂量口服Chyawanprakash没有显示出任何安全性问题,HbA1c水平、临床和实验室参数(血糖、微量白蛋白尿、肝肾功能测试、脂质状况等)没有明显的统计学显着变化。医师对总体安全性的全球评估报告了97%的优良安全性。此外,受试者的能量水平也有统计学上的显著改善。结论:结果表明Chyawanprakash在Ⅱ型糖尿病患者中的适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Role of Unani Medicine in the Management of Tinnitus (Taneen) Stimulation of Phagocytosis in Alveolar Macrophages and Resistance against Infection in Mice by the Aqueous Extract of Rhizomes of Aframomum danielli, Schum (zingiberaceae) Efficacy of Fibromyalgia Treatment Using Bach Flower Therapy: Preliminary Results Challenges of Inappropriate Antibiotic Prescription in Dentistry and Threat of Antimicrobial Resistance in Developing Countries - Medicinal Plants to the Rescue Treatment of Dementia Symptoms: Scoping Review of Complementary and Alternative Medicine Approaches
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1